clinical trial market, pharmceuticals market, market researc

1. Singapore Clinical Trial Market Opportunity Analysis Bharat Book Bureau

2. Summary Singapore has off late come to become the nucleus of clinical research activities in the Asia-Pacific region. The country is a natural hub for manufacturers and clinicians. It also possesses one of the best healthcare infrastructure networks in the entire region. Singapore is the third largest market in Asia for conducting clinical trials. The national government has been extremely supportive in developing clinical research activities and maintaining high immunization rates. The Singapore government in recent years has invested approximately USD1.1 billion into vaccine, translational and biomarker research. Additionally, the stringent intellectual-property laws and good clinical practice (GCP) guidelines is a significant source of security and assurance to the clients in the pharmaceuticals industry. Thus, the country is seen to have a great potential to capture the growth of the clinical trials industry not merely due to its strategic location, but also owing to its reputation of having a strong regulation in the biotech and pharmaceutical markets.

3. Continue… It has been estimated that during the period 2010-2012, approximately 200 Clinical Trial Certificates were issued annually. A major proportion of these studies would be in the Phase 1 to 3 stage of drug development. Some of the most important therapeutic areas which would be focused in these trials would include oncology, clinical pharmacology, gastroenterology/ hepatology and cardiology. These areas represent the niche fields where Singapore has not yet completely built its medical expertise. The Singapore Good Clinical Practice (GCP) Guidelines were set up by the Ministry of Health in 1998. These guidelines ensure patient safety and the integrity of the resulting data.

4. Table Of Contents 1. Singapore Clinical Trial Market Overview1.1 Market Overview1.1.1 Clinical Trial by Phase1.1.2 Clinical Trial by Therapeutic Area1.2 Favorable Market Dynamics1.3 Challenges to be Resolved2. Disease Prevalence in Singapore3. Patient Recruitment & Cost Analysis4. Regulatory Framework to Conduct Clinical Trial4.1 Certificate for Initiating Clinical Trial4.2 Certificate for Import of Test Materials4.3 Procedure for Advertisement/Recruitment Programme4.4 Procedure for Extension of Clinical Trial Certificate4.5 Good Clinical Practice Inspection Framework

5. Related Reports • Russia Clinical Trial Market Opportunity Analysis • Joint Pain Global Clinical Trials Review, H1, 2013 • Post-Operative Pain Global Clinical Trials Review, H1, 2013 • Dysphagia Global Clinical Trials Review, H1, 2013 • Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration

6. About us: Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

7. For More Information You Can Visit- http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/singapore-clinical-trial-market-opportunity-analysis.html Or visit us at: Bharat Book BureauPhone : +91 22 27810772, 27810773 Fax : +91 22 27812290 Call UK: +44 7405 208461 Toll Free No for USA/Canada : 1-866-279-8368 E-mail : info@bharatbook.com Website : www.bharatbook.com Follow us on : Request Sample Pages